RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
119 hedge funds and large institutions have $1.14B invested in Ra Pharmaceuticals, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 59 increasing their positions, 27 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
11% less capital invested
Capital invested by funds: $1.29B → $1.14B (-$140M)
28% less call options, than puts
Call options by funds: $359K | Put options by funds: $499K
Holders
119
Holding in Top 10
5
Calls
$359K
Puts
$499K
Top Buyers
| 1 | +$50.8M | |
| 2 | +$17.4M | |
| 3 | +$15.3M | |
| 4 |
BlackRock
New York
|
+$14.9M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$12.9M |
Top Sellers
| 1 | -$20.5M | |
| 2 | -$9.02M | |
| 3 | -$6.13M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$5.56M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$5.07M |